About the Union for International Cancer Control (UICC)

The Union for International Cancer Control (UICC) is a membership organisation that unites and supports the cancer community to reduce the global cancer burden, promote greater equity, and ensure that cancer control continues to be a priority in the world health and development agenda. Founded in 1933 and based in Geneva, UICC’s growing membership of over 1150 organizations across 170 countries and territories features the world’s major cancer societies, cancer centres, ministries of health, research institutes, and patient groups. Fostering inclusive partnerships represents the foundation of how UICC operates and delivers impact. This is why UICC works hand in hand with a variety of stakeholders to drive changes and make progress in the fight against cancer.

About the ATOM Coalition

The Access to Oncology Medicines (ATOM) Coalition is a global initiative led by UICC in collaboration with over 40 partners across the private and civil society sectors. The ATOM Coalition aims to reduce cancer-related suffering and deaths by addressing barriers to the availability, affordability, and appropriate use of oncology medicines in low- and lower-middle-income countries (LLMICs). The Coalition focuses on strengthening the capacity of countries and systems, increasing the availability of essential generics and biosimilars, and enabling access to innovative medicines.

Summary of the position

UICC seeks a Market Access Lead for strategic market access planning, business case development, and operationalising sustainable access pathways. S/he will work closely with pharmaceutical and diagnostic companies to facilitate access to critical medicines and technologies while bringing market dynamic analyses to bare for country implementation and uptake.

Main responsibilities

• Conduct detailed analysis of ATOM Coalition countries to build baseline data on macroeconomics, health and cancer infrastructure, cancer funding, regulatory affairs, supply chain, medicine and diagnostic availability.
• Build a model to estimate demand for medicines and diagnostics in ATOM countries.
• Develop evidence-based business cases for introducing critical generic and innovative medicines and priority diagnostics.
• Collaborate with pharmaceutical and diagnostic company partners to operationalise access through the sustainable access pathways, working with partner teams such as access, manufacturing, regulatory, region or countries, and/or finance.
• Assess pain points and opportunities in the supply chain specific to cancer medicines and diagnostics and provide data and insights to the country support team and pharmaceutical and diagnostic company partners.
• Adapt the go-to-market strategy as relevant.
• Leverage ATOM country market analysis data to inform global efforts, discussions and outputs.
• Employ horizon scanning to track evolving payer archetypes across key markets, enabling scenario planning for reimbursement.
• Build country-specific access roadmaps, incorporating horizon scanning, market dynamics, scenario planning and reimbursement options, in close collaboration with the country support team.
• Work closely with coalition partners enabling access (sustainable access pathway partners of Medicines Patent Pool, IDA Foundation and the Max Foundation) to share data, lessons and co-create solutions.
• Monitor regulatory and pricing environments to propose solutions for improving affordability and timely availability of medicines and diagnostics.

Education and experience

• Master's degree in health economics, business administration or related field
• Minimum of 5-7 years' experience in market access, commercial or finance roles with a strong track record of driving impactful initiatives
• Minimum of 5 years’ experience in the pharmaceutical industry
• Preference for candidates with a successful track record of launching medicines or diagnostics in LMICs

Skills and competencies

• Experience in LMICs required; experience in the public sector a strong asset
• Strong understanding of payer and access stakeholder needs in LMICs across multiple regions
• Excellent communication skills to simplify complex data for a general audience
• Proven ability to convene multisectoral stakeholders towards consensus-driven solutions
• Strong project management skills
• Fluency in pharmacoeconomic modelling
• Familiarity with cancer medicines and diagnostics an advantage
• Ability to work effectively in a multicultural environment with diverse stakeholders
• Fluent in English

Travel requirements

This role requires approximately 10% travel

Applications

Send your CV and motivation letter explaining how you think your skills and experience make you a strong candidate. Please address your application to: careers@uicc.org

Applications received will be evaluated on a rolling basis until the candidate has been identified.

The candidate should have a Swiss work permit or be eligible to work in Switzerland.